A Study of Zasocitinib in Adults With Nonsegmental Vitiligo

Last updated:
2026-07-18
Language and content disclaimer

The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.

Linking to Non-Government of Canada Websites

Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.

Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.

View trial details

Overview

Official protocol title:

A PHASE 2, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, DOSE RANGING TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ZASOCITINIB IN PARTICIPANTS WITH NONSEGMENTAL VITILIGO

Intervention/treatment:
ZASOCITINIB (TAK-279)
Medical condition:
VITILIGO
Protocol code:
TAK-279-VT-2001
Control number:
301373
Status:
Recruiting
Approved:
October 02, 2025
Trial phase:
Phase 2
For more information:
ClinicalTrials.gov - NCT07108283
This is an external link. The information is not authorized by the Government of Canada.

Eligibility

Sex: ALL
Age
18 Years to 75 Years
Accepts healthy volunteers: No

Contacts and locations

Contact
Name
Takeda Contact
Role
CONTACT
Phone:
+1-877-825-3327
Sponsor
TAKEDA DEVELOPMENT CENTER AMERICAS INC

Locations

New Brunswick

Brunswick Dermatology Center (BDC)
Fredericton, New Brunswick, E3B 1G9
RECRUITING
Name
Site Contact
Role
CONTACT
Phone:
506 459-1808; 506-459-1808
Name
Irina Turchin
Role
PRINCIPAL_INVESTIGATOR

Ontario

LEADER research
Hamilton, Ontario, L8L 3C3
RECRUITING
Name
Site Contact
Role
CONTACT
Phone:
289-812-0046
Name
Jose Hermenio Cavalcante Lima Filho
Role
PRINCIPAL_INVESTIGATOR
North York Research Inc
Toronto, Ontario, M2N 3A6
RECRUITING
Name
Site Contact
Role
CONTACT
Phone:
4162227546
Name
Firouzeh Niakosari
Role
PRINCIPAL_INVESTIGATOR
SimcoDerm Medical and Surgical Dermatology Centre
Barrie, Ontario, L4M 7G1
RECRUITING
Name
Site Contact
Role
CONTACT
Phone:
705-503-6331; 705-503-6333
Name
Maryam Shayesteh Alam
Role
PRINCIPAL_INVESTIGATOR
SKiN Centre for Dermatology
Peterborough, Ontario, K9J 5K2
RECRUITING
Name
Site Contact
Role
CONTACT
Phone:
705-775-0295
Name
Melinda Gooderham
Role
PRINCIPAL_INVESTIGATOR
The Centre for Clinical Trials
Oakville, Ontario, L6J 7W5
RECRUITING
Name
Site Contact
Role
CONTACT
Phone:
905-842-2262
Name
Sheetal Sapra
Role
PRINCIPAL_INVESTIGATOR

Quebec

Centre de Recherche Dermatologique de Quebec
Québec, Quebec, G1V 4X7
RECRUITING
Name
Site Contact
Role
CONTACT
Name
Julien Ringuet
Role
PRINCIPAL_INVESTIGATOR

Saskatchewan

Skinsense Medical Research
Saskatoon, Saskatchewan, S7K 2C1
RECRUITING
Name
Site Contact
Role
CONTACT
Name
Kirsten Walker
Role
PRINCIPAL_INVESTIGATOR
Did you find what you were looking for?